Motley Fool96d agobullish
1 Wall Street Analyst Thinks Tilray Will Soar Nearly 75%. Is It a Buy Now?International growth could make up for a lack of U.S. legalization progress
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
359last 24h
2367last 7d
427● bullish (7d)
220● bearish (7d)
202publishers
Zacks96d agoneutral
Tilray Brands, Inc. (TLRY) Is a Trending Stock: Facts to Know Before Betting on ItRecently, Zacks.com users have been paying close attention to Tilray Brands (TLRY). This makes it worthwhile to examine what the stock has in store.
Motley Fool97d agoneutral
Is Tilray the Best Value Play in the $7.4 Billion Cannabis Beverage Market?Or is it just a value trap?
Zacks97d agoneutral
Should SNDL Stock Be in Your Portfolio Post Q1 Earnings?SNDL faces pressure after Q1 results show falling sales, weak cannabis demand, and margin strain, raising concerns about growth in a saturated Canadian market.
Motley Fool100d agoneutral
Why Tilray's Marijuana Rescheduling Sizzle Has FizzledMost regulatory headwinds remain for cannabis companies like Tilray.
Motley Fool101d agoneutral
Tilray Brands to Expand Into the U.S. Marijuana Market? Why You Shouldn't Count on That Anytime SoonMarijuana rescheduling may have taken place in the U.S., but that doesn't mean legalization will happen anytime soon.
Insider Monkey102d agoneutral
Tilray (TLRY) CEO on Potential US Cannabis ReclassificationTilray Brands, Inc. (NASDAQ:TLRY) is one of the 7 Best Hemp Stocks To Buy Now. On April 22, Bloomberg reported, citing an on-air discussion with CEO Irwin Simon, that Tilray Brands, Inc. (NASDAQ:TLRY) shares rose by around 10% after surging as much as 18% earlier, amid strong trading activity of more than 20 million shares. […]
Motley Fool108d agoneutral
Is Tilray a Textbook Example of a Value Trap?Tilray doesn't fit squarely into the value trap or value stock categories.
TheStreet109d agoneutral
Tilray just showed how fast a policy trade can cool offTilray Brands (TLRY) surged in premarket trading on fresh enthusiasm over marijuana rescheduling, then gave back much of the move as the session unfolded. The early excitement followed a U.S. government shift to reclassify certain marijuana products and a market rush into cannabis names. By later ...
Barrons.com110d agoneutral
Medical Marijuana Reclassified as Less Dangerous Drug. Pot Stocks Go Up in Smoke.The Trump administration also announced the beginning of an expedited administrative hearing process to consider the rescheduling marijuana more broadly.